Elliptic Laboratories AS
Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on… Read more
Elliptic Laboratories AS (ELABS) - Total Liabilities
Latest total liabilities as of September 2025: Nkr25.74 Million NOK
Based on the latest financial reports, Elliptic Laboratories AS (ELABS) has total liabilities worth Nkr25.74 Million NOK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Elliptic Laboratories AS - Total Liabilities Trend (2017–2024)
This chart illustrates how Elliptic Laboratories AS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Elliptic Laboratories AS Competitors by Total Liabilities
The table below lists competitors of Elliptic Laboratories AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Global Green Chemicals Public Company Limited
BK:GGC
|
Thailand | ฿1.61 Billion |
|
Popular Vehicles and Services Limited
NSE:PVSL
|
India | ₹15.52 Billion |
|
Nila Spaces Limited
NSE:NILASPACES
|
India | ₹2.38 Billion |
|
Done.ai Group AB
ST:DONE
|
Sweden | Skr232.15 Million |
|
Cibl Inc.
PINK:CIBY
|
USA | $629.00K |
|
Faze Three Limited
NSE:FAZE3Q
|
India | ₹3.29 Billion |
|
Lantern Pharma Inc
NASDAQ:LTRN
|
USA | $4.04 Million |
|
Everbright Digital Holding Limited Ordinary Shares
NASDAQ:EDHL
|
USA | $532.65K |
Liability Composition Analysis (2017–2024)
This chart breaks down Elliptic Laboratories AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 3.09 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elliptic Laboratories AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elliptic Laboratories AS (2017–2024)
The table below shows the annual total liabilities of Elliptic Laboratories AS from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr35.69 Million | -16.62% |
| 2023-12-31 | Nkr42.80 Million | +80.57% |
| 2022-12-31 | Nkr23.70 Million | -17.09% |
| 2021-12-31 | Nkr28.59 Million | -6.63% |
| 2020-12-31 | Nkr30.62 Million | -48.40% |
| 2019-12-31 | Nkr59.34 Million | +8.19% |
| 2018-12-31 | Nkr54.84 Million | +106.25% |
| 2017-12-31 | Nkr26.59 Million | -- |